Maximilien Tailler Selected Research

Maximilien Tailler Research Topics

5	Neoplasms (Cancer) 01/2019 - 12/2011
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2011 - 07/2008
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2011 - 07/2008
1	Bites and Stings (Sting) 01/2020
1	Lung Neoplasms (Lung Cancer) 08/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2012
1	Carcinoma (Carcinomatosis) 06/2012
1	Polyploidy 06/2012

3	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2011 - 12/2008
2	Phosphotransferases (Kinase)IBA 01/2020 - 09/2011
2	Gefitinib (Iressa)FDA Link 11/2011 - 12/2008
2	ErbB Receptors (EGF Receptor)IBA 11/2011 - 09/2011
2	Transcription Factors (Transcription Factor)IBA 09/2008 - 07/2008
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2020
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2020
1	Adenosine Monophosphate (AMP)IBA 01/2020
1	Interferon Type IIBA 01/2020
1	InterferonsIBA 01/2020
1	CytokinesIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 09/2012
1	CalreticulinIBA 09/2012
1	CarcinogensIBA 09/2012
1	Cisplatin (Platino)FDA LinkGeneric 08/2012
1	Vitamin B 6IBA 08/2012
1	Cytotoxins (Cytolysins)IBA 08/2012
1	Glutathione (Reduced Glutathione)IBA 08/2012
1	pyrazolanthroneIBA 06/2012
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 06/2012
1	EnzymesIBA 12/2011
1	Adenosine Triphosphate (ATP)IBA 12/2011
1	Antineoplastic Agents (Antineoplastics)IBA 11/2011
1	Tyrosine Kinase InhibitorsIBA 11/2011
1	src-Family KinasesIBA 09/2011
1	TOR Serine-Threonine KinasesIBA 09/2011
1	Tyrosine (L-Tyrosine)FDA Link 09/2011

1	Drug Therapy (Chemotherapy) 12/2011